Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04658862 |
|---|---|
| Brief Title: | A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder (SunRISe-2) |
| First Submitted : | November 19, 2020 |
| First Submitted that Met QC Criteria : | December 7, 2020 |
| First Posted : | December 9, 2020 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |